Tirzepatide (Mounjaro®)
Tirzepatide is a dual GIP and GLP-1 receptor agonist developed for the treatment of type 2 diabetes. Marketed under the brand name Mounjaro®, it helps improve blood glucose control and can reduce appetite and body weight. For research purposes only





Reviews
There are no reviews yet.